ESC 365 - Atrioventricular optimization in cardiac resynchronization therapy with quadripolarleads, improves energy handling and quality of life in heart failure patients: HUMVEE Trial

ESC Premium Access

Atrioventricular optimization in cardiac resynchronization therapy with quadripolarleads, improves energy handling and quality of life in heart failure patients: HUMVEE Trial

Session: Poster Session 5 - Heart failure devices: new approaches

Topic: Cardiac Resynchronisation Therapy (CRT)

Speaker: Doctor C. Antoniou (Athens, GR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Christos-Konstantinos Antoniou

Athens Medical Centre, Athens (Greece)

0 follower

8 more presentations in this session

His bundle pacing in patients pacemaker indication and with mildly reduced ejection fraction

Speaker: Mr R. Gardas (Katowice, PL)

Differential effect of CRT in ischemic and non-ischemic cardiomyopathy: longterm follow-up data from a single center cohort study

Speaker: Doctor P. Kahr (Schlieren, CH)

Implant procedure and lead handling characteristics of a novel active fixation quadripolar lead: Results from the Attain Stability Quad clinical trial

Speaker: Professor S. Faerestrand (Bergen, NO)

Cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy and severe heart failure may influence the development of unstable ventricular tachycardia

Speaker: Doctor D. Lebedev (Kemerovo, RU)

Are there shock incidence and mortality differences in primary prevention patients regarding device type and ischemia? A NORDIC ICD sub-study.

Speaker: Professor H. Bonnemeier (Luebeck, DE)

Access the full session

Poster Session 5 - Heart failure devices: new approaches

Speakers: Doctor C. Antoniou, Mr R. Gardas, Doctor P. Kahr, Professor S. Faerestrand, Doctor D. Lebedev...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources